spacer
The Healthcare Sales & Marketing Network celebrates 23 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  polycystic kidney disease 

 HSMN NewsFeed - 13 Nov 2019
Otsuka Announces Retirement of President & Chief Executive Officer William H. Carson, M.D.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Jun 2017
Regulus Announces Pipeline Updates and Advancements
Biopharmaceuticals
 HSMN NewsFeed - 24 Mar 2014
Otsuka Pharmaceutical's Samsca(R) Approved in Japan as the World's First Drug Therapy for ADPKD, a Rare Kidney Disease
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 27 Dec 2013
European Medicines Agency (EMA) Accepts Otsuka's Marketing Authorisation Application (MAA) for Tolvaptan, an Investigational Compound for Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 9 Jan 2007
AVI BioPharma and Eleos Announce Cross-License Agreement for p53 Therapeutics
Biopharmaceuticals Licensing
 HSMN NewsFeed - 18 Oct 2006
AVI BioPharma Initiates NEUGENE Antisense Clinical Program in Coronary Artery Bypass Grafting
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 3 Aug 2006
AVI BioPharma Provides Cardiovascular Program Update
Biopharmaceuticals Drug Delivery Cardiology
 HSMN NewsFeed - 30 Mar 2006
AVI BioPharma Reports Successful Inhibition of Multiple Subtypes of Influenza A Using NEUGENE Antisense Therapeutic
Biopharmaceuticals
 HSMN NewsFeed - 13 Mar 2006
AVI BioPharma and Cook Group Enter Into License Agreement to Develop NEUGENE Drugs for Vascular Diseases
Devices Biopharmaceuticals Licensing
 HSMN NewsFeed - 23 Feb 2006
Otsuka Maryland Research Institute, Inc. Granted Fast Track Designation for Tolvaptan in PKD
Biopharmaceuticals FDA
 HSMN NewsFeed - 9 Feb 2006
Successful Muscular Dystrophy Treatment Results Using AVI BioPharma Technology Published in Nature Medicine
Biopharmaceuticals
 HSMN NewsFeed - 27 Jan 2006
AVI BioPharma Announces Hepatitis C Virus License Agreement with Chiron
Biopharmaceuticals Licensing
Return to NewsFeed  

 Additional items found! 45

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 45 additional stories matching:
polycystic kidney disease
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.